Trimethoprim-sulfamethoxazole compared with ciprofloxacin for treatment and prophylaxis of Isospora belli and Cyclospora cayetanensis infection in HIV-infected patients - A randomized, controlled trial

Background: In developing countries, Isospora belli and Cyclospora cayetane nsis frequently cause chronic diarrhea in HIV-infected patients. Objective: To compare 1 week of trimethoprim-sulfamethoxazole treatment and 1 week of ciprofloxacin treatment in HIV-infected patients with chronic di arrhea caused by I. belli and C. cayetanensis. Design: Randomized, controlled trial. Setting: HIV clinic in Port-au-Prince, Haiti. Patients: 42 HIV-infected patients with chronic diarrhea due to I. belli (n = 22) or C. cayetanensis (n = 20). Interventions: Patients were randomly assigned to receive oral trimethoprim -sulfamethoxazole (160 mg or 800 mg) or ciprofloxacin (500 mg) twice daily for 7 days. Patients who responded clinically and microbiologically receive d prophylaxis for 10 weeks (1 tablet orally, three times per week). Measurements: Treatment success was measured by cessation of diarrhea and n egative stool examination at day 7. Prophylaxis success was measured by rec urrent disease rate. Results: Diarrhea ceased in all 19 patients treated with trimethoprim-sulfa methoxazole. Eighteen of 19 patients had negative results on stool examinat ion at day 7 (95%). Among the 23 patients who received ciprofloxacin, diarr hea ceased in 20 (87% [Cl, 66% to 97%]) and 16 had negative results on stoo l examination at day 7 (70%). By survival analysis, diarrhea from isosporia sis and cyclosporiasis ceased more rapidly with trimethoprim-sulfamethoxazo le than with ciprofloxacin. All patients receiving secondary prophylaxis wi th trimethoprim-sulfamethoxatole remained disease-free, and 15 of 16 patien ts receiving secondary prophylaxis with ciprofloxacin remained disease-free . Conclusions: A 1-week course of trimethoprim-sulfamethoxazole is effective in HIV-infected patients with cyclosporiasis or isosporiasis. Although cipr ofloxacin is not as effective, it is acceptable for patients who cannot tol erate trimethoprim-suifamethoxazole.